MyFinsight
Home
Blog
About
Innovative Medicine
$16,384M
(7.78%↑ Y/Y)
Med Tech
$8,926M
(4.51%↑ Y/Y)
Sales to customers
(note 9)
$25,310M
(6.60%↑ Y/Y)
Gross profit
$17,259M
(7.10%↑ Y/Y)
Interest income
$219M
(-15.77%↓ Y/Y)
Cost of products sold
$8,051M
(5.55%↑ Y/Y)
Earnings before
provision for taxes on...
$6,747M
(3.94%↑ Y/Y)
Selling, marketing and
administrative expenses
$6,432M
(9.22%↑ Y/Y)
Research and development
expense
$3,653M
(3.90%↑ Y/Y)
Other (income)
expense, net
-$331M
(-209.35%↓ Y/Y)
Interest expense, net of
portion capitalized
$281M
(-8.77%↓ Y/Y)
Restructuring (note 12)
$34M
(-46.88%↓ Y/Y)
Net earnings
$5,534M
(-0.05%↓ Y/Y)
Provision for taxes on
income (note5)
$1,213M
(27.15%↑ Y/Y)
Back
Back
Income Statement
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
source: myfinsight.com
JOHNSON & JOHNSON (JNJ)